Production of C-reactive protein and risk of coronary events in stable and unstable angina

Lancet

Volumn 349, Issue 9050, 1997, Pages 462-466

  Haverkate, Frits ^a   Thompson, Simon G ^b   Pyke, Stephen D M ^b   Gallimore, J Ruth ^c   Pepys, Mark B ^c  

^a TNO   (Netherlands)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; SERUM AMYLOID A; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANAMNESIS; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

EID: 0031054058     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07591-5     Document Type: Article

References (30)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-09.
2. Bhakdi S, Dorweiler B, Kirchmann R, et al. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med 1995; 182: 1959-71.
3. Mattila KJ, Nieminen MS, Valtonen V, et al. Association between dental health and acute myocardial infarction. BMJ 1989; 298: 779-81.
4. Hendrix MGR, Daemen M, Bruggeman CA. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 1991; 138: 563-67.
5. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273-78.
6. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-94.
7. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-14.
8. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141-212.
9. Pepys MB. Acute phase proteins in the acute response. London: Springer-Verlag, 1989.
10. Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for C-reactive protein. Clin Chim Acta 1981; 117: 13-23.
11. Wilkins J, Gallimore JR, Tennent GA, et al. Rapid automated enzyme immunoassay of serum amyloid A. Clin Chem 1994; 40: 1284-90.
12. Pepys MB. The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford textbook of medicine, third edition. Oxford: Oxford University Press, 1995: 1527-33.
13. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 1351-57.
14. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
15. Heinrich J, Schulte H, Schönfeld R, Köhler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemostas 1995; 73: 374-78.
16. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990; 65: 168-72.
17. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-41.
18. Grossman W. Cardiac catheterization and angiography. Philadelphia: Lea and Febiger, 1986.
19. ECAT Angina Pectoris Study Group. ECAT Angina Pectoris Study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993; 14: 8-17.
20. Jespersen J, Bertina RM, Haverkate F. ECAT assay procedures: a manual of laboratory techniques. Dordrecht: Kluwer Academic Publishers, 1992.
21. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1-30.
22. Maseri A, Biasucci LM, Liuzzo G. Inflammation in ischaemic heart disease. BMJ 1996; 312: 1049-50.
23. Liuzzo G, Biasucci LM, Rebuzzi AG, et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996; 94: 2373-80.
24. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study. BMJ 1996; 312: 1061-65.
25. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513-20.
26. Pepys MB, Rowe IF, Baltz ML. C-reactive protein: binding to lipids and lipoproteins. Int Rev Exp Pathol 1985; 27: 83-111.
27. Volanakis JE, Narkates AJ. Interaction of C-reactive protein with artificial phosphatidyl-choline bilayers and complement. J Immunol 1981; 126: 1820-25.
28. Volanakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci 1982; 389: 235-50.
29. van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993; 32 (suppl 3): 9-13.
30. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart-disease in the MRFIT nested case control study. Am J Epidemiol 1996; 144: 537-47.